Domingo Halliburton
Handmade in USA
BYND Meats seems Overvalued to me. $4B company with $50MM in revs and no profits. Opinions seem to be all over the place on it though.
Boiler Room: The Official Stock Market Discussion
Domingo Halliburton
Handmade in USA
Morgan stanley private memo leaked regarding tesla. This Jonas guy us3d to be one of the biggest TSLA bulls on the street.
Highlights:
"Tesla is... A distressed credit and restructuring story."
"Even at a zero dollar equity value, the enterprise value to sales ratio of Tesla would be fifty percent or so higher than a VW. It would be in the range of a BMW EV to sales. At zero dollars!"
"They've built this hulking physical infrastructure to supply more like a million cars a year. Not 350,000 cars a year. Right? And that's what... That's what's creating this bleeding."
"To be simple about it [...] Does demand recover or not? Okay? And then... And then, whether demand recovers or not, is it convincingly sustainable?
"If demand does not recover, and one could argue that many signs in the fixed income market would tell you that there's questions to that, then this becomes a restructuring story. We think that, 'yes, that's right, Tesla, tech company, the auto industry's biggest restructuring story?' And people will begin to a— run scenarios about management—a management team that really went in there and cleaned house. What could they do to lower the break-even point? In terms of head count reductions or writedowns for risk mitigation and liability containment, **
[Apple] may not want to expose themselves to the unlimited liability of being involved in owning a business where occasionally a car catches on fire... takes down a building... Perhaps those big tech firms don't want to expose themselves to that up-front, and moreover, they realize that the autonomous 'race' is more of a marathon, where over a ten or twenty-year period you collect real-world miles."
Highlights:
"Tesla is... A distressed credit and restructuring story."
"Even at a zero dollar equity value, the enterprise value to sales ratio of Tesla would be fifty percent or so higher than a VW. It would be in the range of a BMW EV to sales. At zero dollars!"
"They've built this hulking physical infrastructure to supply more like a million cars a year. Not 350,000 cars a year. Right? And that's what... That's what's creating this bleeding."
"To be simple about it [...] Does demand recover or not? Okay? And then... And then, whether demand recovers or not, is it convincingly sustainable?
"If demand does not recover, and one could argue that many signs in the fixed income market would tell you that there's questions to that, then this becomes a restructuring story. We think that, 'yes, that's right, Tesla, tech company, the auto industry's biggest restructuring story?' And people will begin to a— run scenarios about management—a management team that really went in there and cleaned house. What could they do to lower the break-even point? In terms of head count reductions or writedowns for risk mitigation and liability containment, **
[Apple] may not want to expose themselves to the unlimited liability of being involved in owning a business where occasionally a car catches on fire... takes down a building... Perhaps those big tech firms don't want to expose themselves to that up-front, and moreover, they realize that the autonomous 'race' is more of a marathon, where over a ten or twenty-year period you collect real-world miles."
Last edited:
Domingo Halliburton
Handmade in USA
Lol at the volume for the June $40 TSLA puts having a volume of over 18,000.
The implied volatility is making the options cost so much people are messing around down there with these strikes at like $10, $20, $30, etc.
The implied volatility is making the options cost so much people are messing around down there with these strikes at like $10, $20, $30, etc.
the fukkin s&p is down 1.7% :deadjay: im about to lose like 8 grand today
colicolicoli
Droid Gang
Bought some $OTLK stock on the low. Prob gonna dump it quickly but it's doing well this week
Update: Got 200 shares @ $2.45. Currently at $2.60 and I'm hoping it hits $3. I should have bought more. IDK what I'm doing but this is my second pick and it's doing well. I need to put more money towards this shyt to start making real money.
Update: Got 200 shares @ $2.45. Currently at $2.60 and I'm hoping it hits $3. I should have bought more. IDK what I'm doing but this is my second pick and it's doing well. I need to put more money towards this shyt to start making real money.
Last edited:
shagnificent belafonte
I am he who lurks...
Made a quick $600 off HIBB...bought two options yesterday and sold em today
I could never get into Robinhood. Sometimes you get what you pay for and it's one of those cases. Fidelity charges like $5 a trade. It's not that bad. Those fees really only come into play when you're buying a handful of shares.
colicolicoli
Droid Gang
Maybe Trump tells his friends a day before he tweets so they can dump their stocks.. This has happened a couple times now it seems like a pattern.
Think about it this way. At the moment, it is estimated that more than 35 million Americans or more than 10% of the United States population are using statin-based treatments. A large percentage of these see persistent high cholesterol levels.
In the past, the American Heart Association recommended the use of baby aspirin to control risk of cardiovascular events in this population. However, the AHA has pulled its recommendation. Moreover, there are absolutely no treatments on the market with this indication, leading to a vast medical need.
Considering everything that Vascepa has going for it, should the sNDA be approved, AMRN could be sitting on a blockbuster drug that is quickly adopted by the high cardiovascular risk community in the United States and around the world.
Amarin (AMRN) Stock: A Blockbuster In The Making | Alpha Stock News
In the past, the American Heart Association recommended the use of baby aspirin to control risk of cardiovascular events in this population. However, the AHA has pulled its recommendation. Moreover, there are absolutely no treatments on the market with this indication, leading to a vast medical need.
Considering everything that Vascepa has going for it, should the sNDA be approved, AMRN could be sitting on a blockbuster drug that is quickly adopted by the high cardiovascular risk community in the United States and around the world.
Amarin (AMRN) Stock: A Blockbuster In The Making | Alpha Stock News